Amarin

Focused on reducing cardiovascular risk and helping more patients live healthier, longer lives. CGs: for U.S residents only.

[Amarin @Amarincorp]

Summer is a great time to focus on healthy habits and understanding your cardiovascular health.

Knowing your cholesterol, triglycerides, blood pressure, and blood sugar levels can help inform important conversations about risk and prevention.

#KnowYourNumbers #HeartHealth #PreventionMatters

[Amarin @Amarincorp]

Summer vacations may be on the calendar, but cardiovascular risk doesn't take the season off.

Knowing your cholesterol, triglycerides, blood pressure, and blood sugar levels can help you better understand your cardiovascular health.

Know your numbers. Know your risk.

#HeartHealth #KnowYourNumbers #DiseasePrevention

[Amarin @Amarincorp]

We're looking forward to sharing our Q2 2026 financial results and business update on Wednesday, July 29 at 8:00 a.m. ET.

Register for the live webcast: https://t.co/EtQhsQGyf9

#InvestorRelations #EarningsCall #Healthcare #Amarin

[Amarin @Amarincorp]

What's in Your Summer Scorecard?

[Amarin @Amarincorp]

Fireworks. Family. Freedom. ❤️🤍💙

This Independence Day, we're reminded that protecting your heart health can help you enjoy more of life's meaningful moments.

Wishing everyone a safe and healthy Fourth of July.

#FourthOfJuly #HeartHealth #DiseasePrevention

[Amarin @Amarincorp]

New WomenTalk episode from @HealthyWomen on women’s CV risk + why triglyceride levels matter.

Greater awareness of women’s heart health can help drive earlier conversations, more informed care decisions, and improved patient outcomes.
https://t.co/meYsDRurFl

[Amarin @Amarincorp]

Innovative advances are bringing renewed attention to severe hypertriglyceridemia (sHTG) and the risks associated with very high triglycerides, including acute pancreatitis.

As treatment options continue to evolve, improving outcomes means ensuring patients have access to therapies that are evidence-based, accessible, and affordable.

Read more: https://t.co/YooG2jnVIr

[Amarin @Amarincorp]

Cardiovascular health disparities remain a critical public health challenge.

Black Americans are more likely to develop cardiovascular disease at younger ages and experience more severe outcomes. Nearly half of Black adults live with hypertension, a leading risk factor for heart disease and stroke.

Awareness and early intervention matter.
#HeartHealth #HealthEquity

[Amarin @Amarincorp]

June is #MensHealthMonth - a reminder that prevention starts with knowing your cardiovascular risk.

Heart disease remains a leading cause of death in men, often developing silently. Talk to your doctor about cholesterol, triglycerides, BP, blood sugar & family history.

#HeartHealth #PreventiveCare

[Amarin @Amarincorp]

This week at #NLA2026, Zachary M. Salvati, MS, CGC, shared new Geisinger data on improving care for patients with HTG after ACS highlighting the real-world barriers and strategies to better align with evolving guidelines.

#CardiovascularHealth #PreventionFirst #HTG

[Amarin @Amarincorp]

Learn more: https://t.co/5px4dXLjZ4

[Amarin @Amarincorp]

Newly released AHA/ACC/Multisociety Guideline on CKM Syndrome highlights comprehensive heart, kidney, & metabolic risk assessment & prevention, including consideration of icosapent ethyl for appropriate patients with persistent hypertriglyceridemia on maximally-tolerated statins.

[Amarin @Amarincorp]

It was great to connect with fellow investors and industry peers and engage in insightful conversations about the future of healthcare at the Goldman Sachs Annual Global Healthcare Conference 2026. Thank you to everyone who made the event a success.

#Healthcare #InvestorReations

[ASPC @ASPCardio]

🚨 The first-ever CKM Syndrome guideline just dropped — and it changes how we approach cardiometabolic-renal care.

2026 AHA/ACC/ADA/ASN Guideline for Prevention, Detection, Evaluation & Management of Cardiovascular-Kidney-Metabolic Syndrome. 🧵

Key highlights:
🔵 CKM staging for all ages
🔵 PREVENT equations for 10/30-yr risk
🔵 SGLT2i + GLP-1 GDMT for T2D + CVD risk
🔵 RASi + SGLT2i first-line for CKD
🔵 IPE for persistent HTG on statins
🔵 CAC to guide preventive therapy selection
🔵 SDOH screening integrated

📄 Read the full guideline: https://t.co/KLvIQMI3Ym

#CKMSyndrome #PreventiveCardiology #ASPC #GDMT

[Amarin @Amarincorp]

New data from a post hoc analysis of REDUCE-IT presented this week at ESCI Congress in Lisbon explores how icosapent ethyl may impact coagulation biomarkers & clinical outcomes in high-risk cardiovascular patients.

Session details:https://t.co/7yiAPWUXVh

#ClinicalResearch #ESCI

[Amarin @Amarincorp]

Cardiovascular risk goes beyond LDL.

At @MountSinaiNYC, @DLBHATTMD led an immersive educational experience on residual CV risk, welcoming #cardiology specialists from Spain through a collaboration with MAYO Best Practice & Recordati.

@mountsinaiheart @icahnmountsinai

[Amarin @Amarincorp]

Proud to be in Athens with our partner Recordati at #EASCongress2026. Post hoc REDUCE-IT placebo arm data suggest risk-weighted apoB may provide stronger insight into residual CV risk vs traditional lipid markers in statin-treated patients w/ elevated TGs

https://t.co/7ZSpCJgOqv

[Amarin @Amarincorp]

This #StrokeAwarenessMonth: prevention is critical - especially for those at high CV risk. Risk factors like high cholesterol, high triglycerides, high BP, diabetes & smoking can all increase stroke risk. Act early.

More: https://t.co/LlW0bTy3Mi
https://t.co/F98oYpHeHe

[Amarin @Amarincorp]

#WomensHealthMonth reminder: Cardiovascular disease is still the leading cause of death for women. Know your numbers (like cholesterol & triglycerides). Know your risk. Advocate for yourself. Education is a very powerful first step in prevention.

https://t.co/rGuZsfotGn

[Amarin @Amarincorp]

Great to see strong engagement at our recent physician associate (PA) educational roundtable in Jacksonville, FL, supported by @FAPAOnline, led by Dr. John Osborne.

Thanks to everyone who attended.